0001104659-23-005478 4 1 20230118 20230120 20230120 White Mark K. 0001786183 4 34 001-39202 23542073 227 7TH AVENUE NE ST. PETERSBURG FL 33701 Annovis Bio, Inc. 0001477845 2834 262540421 DE 1231 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 QR Pharma, Inc. 20091202 4 1 tm234043-4_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2023-01-18 0 0001477845 Annovis Bio, Inc. ANVS 0001786183 White Mark K. C/O ANNOVIS BIO, INC. 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 1 0 0 0 Stock Option (right to buy) 13.17 2023-01-18 4 A 0 5967 0 A 2033-01-18 Common Stock 5967 5967 D The stock option shall vest in eight consecutive equal quarterly installments each on the 18th day of April, July, October and January of each year, commencing April 18, 2023, and continuing through January 18, 2025. /s/ Henry Hagopian III, Attorney-in-Fact for Mark White 2023-01-20